The 5th edition of the World Health Organization (WHO) Classification of Hematolymphoid Tumors recognizes acute promyelocytic leukemia (APL) as a subtype of acute myeloid leukemia (AML) defined by the presence of a genetic abnormality, namely the PML::RARA gene fusion [1]. This evidence concerns the gene RARA and acute myeloid leukemia.